
WEEKLY E-NEWS FROM THE NORTH CAROLINA BIOTECHNOLOGY CENTER
February 5, 2009
Where can you see a governor, a Nobel prize winner, industry and academic leaders, and many more on a single stage? At the Raleigh Convention Center on Feb. 16 and 17. Join us for Biotech 2009. Listen to the Podcast announcement.
IN FOCUS FEATURE
FROM OUR WEB SITE

In Focus
Biotechnology Program Connects Post-Docs with Companies
North Carolina biotechnology companies have until March 1 to apply to become sponsor companies in this year's Industrial Fellowship program. The program places recent Ph.D. graduates into North Carolina biotechnology companies for a two-year fellowship to gain industry-oriented research experience - and thus improve their competitiveness for high-level industry scientific positions.
Read more about the program and how to apply in this week's In Focus.
|

| Leader Interviews
Meet Christy Shaffer. She's the president and CEO of Inspire Pharmaceuticals in Durham — and has served as a member of the North Carolina Biotechnology Center board of directors. She is featured this week on I Am Biotech, where in a three-part interview, she discusses how she got involved in biotech and why she is so passionate about her work on treatments for Cystic Fibrosis. |
From Our Web Site
BioDelivery Sciences of Raleigh has reported encouraging Phase I clinical trial results for Bioral Amphotericin B, its lead product candidate incorporating its Bioral drug delivery technology.
Durham's Inspire Pharmaceuticals got the go-ahead from the FDA to try another Phase III clinical trial for its experimental dry-eye treatment, Prolacria.
Raleigh's BioMarck Pharmaceuticals has received $990,000 of a $3 million, three-year grant from the National Institutes of Health to help it develop its experimental inhaled treatment for lung disease.
The University of North Carolina at Chapel Hill spin-out company is developing a new type of anti-bacterial treatment that could help stem the tide of deaths and complications from hospital-acquired, drug-resistant infections.
Targacept announced that J. Donald deBethizy, Ph.D., President and Chief Executive Officer, is scheduled to present at the 11th Annual BIO CEO and Investor Conference.
Medical device maker ConvaTec has settled on Greensboro to expand its manufacturing operations.
Vince Mendenhall, D.V.M., Ph.D., joins Wake Forest University Baptist Medical Center as director of the new preclinical surgical services section.
Morrisville-based Mardil reported that its first human test, in India, shows promise for its experimental heart device in treating valve problems.
News from Other Sites
BioMarck Receives $990,000 NIH Grant
The Raleigh company working on new medicines for pulmonary diseases, will fund clinical tests of its experimental treatment for chronic obstructive pulmonary disease (COPD).
From Local Tech Wire
From the Raleigh News & Observer
Biotech Conference will Feature NCRC
The biotech hub in Kannapolis scored a one-hour panel discussion at Biotech 2009, the 18th annual conference hosted by the Council for Entrepreneurial Development in Raleigh.
From the Salisbury Post
N.C. Research Campus Ready for Jobs to Come
The Research Campus, with its three massive but mostly empty buildings outfitted with some of the world's best scientific equipment, could launch projects that would put people to work immediately.
From the Salisbury Post
Community Watch
- Wilmington-based Gene Express has signed a non-exclusive distribution agreement with Biogenuix Medsystems giving the New Delhi marketing, distributing and contract research firm rights to distribute Gene Express's Standardized RT-PCR reagents and research molecular diagnostic products in India. More
- Jorge Leon, Ph.D., one of the founders of the molecular diagnostics and applied genomics business at Quest Diagnostics, has joined the scientific advisory board of ParagonDx, a Morrisville genetic and molecular testing diagnostics company. Leon, of St. Paul, Minn., started a consulting business in 2002. More
- bioMerieux, a French medical diagnostics company with U.S. headquarters in Durham, has signed an exclusive referral agreement with Nashville, Tennessee-based ICNet Systems, a purveyor of software targeting infection control in hospitals and other health care settings. ICNet Systems is an affiliate of ICNet Ltd., based in Gloucestershire, England. More
This newsletter was sent Thursday, February 5, 2009. For the latest headlines from North Carolina’s biotechnology industry, please visit the news section of our Web site.
Online subscription management is now available. Please respond to this e-mail if you cannot change your preferences online.